

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid metabolic process (GO:0046655) | 5.49105850 |
| 2 | vitamin transmembrane transport (GO:0035461) | 5.15160429 |
| 3 | protein maturation by protein folding (GO:0022417) | 5.06018972 |
| 4 | folic acid transport (GO:0015884) | 4.97417000 |
| 5 | NADH metabolic process (GO:0006734) | 4.91571224 |
| 6 | purine nucleobase biosynthetic process (GO:0009113) | 4.77920233 |
| 7 | DNA deamination (GO:0045006) | 4.62304620 |
| 8 | proline biosynthetic process (GO:0006561) | 4.50609379 |
| 9 | pantothenate metabolic process (GO:0015939) | 4.46941042 |
| 10 | glycine metabolic process (GO:0006544) | 4.21776267 |
| 11 | cell migration in hindbrain (GO:0021535) | 4.13641829 |
| 12 | modified amino acid transport (GO:0072337) | 4.13112311 |
| 13 | serine family amino acid catabolic process (GO:0009071) | 4.13014463 |
| 14 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.12639085 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.11513022 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 3.98982780 |
| 17 | nuclear envelope reassembly (GO:0031468) | 3.97220057 |
| 18 | mitotic nuclear envelope reassembly (GO:0007084) | 3.97220057 |
| 19 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.93555761 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.90729694 |
| 21 | protein insertion into membrane (GO:0051205) | 3.89301925 |
| 22 | biotin metabolic process (GO:0006768) | 3.87206001 |
| 23 | mitochondrial fusion (GO:0008053) | 3.86924790 |
| 24 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.85176955 |
| 25 | nucleobase biosynthetic process (GO:0046112) | 3.82364244 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 3.75419735 |
| 27 | establishment of mitochondrion localization (GO:0051654) | 3.74380137 |
| 28 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.72049174 |
| 29 | amino acid salvage (GO:0043102) | 3.70627741 |
| 30 | L-methionine salvage (GO:0071267) | 3.70627741 |
| 31 | L-methionine biosynthetic process (GO:0071265) | 3.70627741 |
| 32 | S-adenosylmethionine metabolic process (GO:0046500) | 3.63097244 |
| 33 | iron-sulfur cluster assembly (GO:0016226) | 3.62697290 |
| 34 | metallo-sulfur cluster assembly (GO:0031163) | 3.62697290 |
| 35 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.60231370 |
| 36 | vitamin transport (GO:0051180) | 3.47731914 |
| 37 | serine family amino acid metabolic process (GO:0009069) | 3.46961958 |
| 38 | ribosome assembly (GO:0042255) | 3.46780214 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 3.43565529 |
| 40 | Golgi transport vesicle coating (GO:0048200) | 3.40102905 |
| 41 | COPI coating of Golgi vesicle (GO:0048205) | 3.40102905 |
| 42 | mitochondrion transport along microtubule (GO:0047497) | 3.38519796 |
| 43 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.38519796 |
| 44 | response to misfolded protein (GO:0051788) | 3.37681868 |
| 45 | tRNA methylation (GO:0030488) | 3.37482970 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36331870 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36331870 |
| 48 | cofactor transport (GO:0051181) | 3.31715760 |
| 49 | autophagic vacuole assembly (GO:0000045) | 3.29425197 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.27453575 |
| 51 | proteasome assembly (GO:0043248) | 3.26283873 |
| 52 | protein retention in ER lumen (GO:0006621) | 3.22317513 |
| 53 | serine family amino acid biosynthetic process (GO:0009070) | 3.22135253 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 3.20832531 |
| 55 | intestinal cholesterol absorption (GO:0030299) | 3.20568077 |
| 56 | glutamate secretion (GO:0014047) | 3.20485815 |
| 57 | cysteine metabolic process (GO:0006534) | 3.20356835 |
| 58 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.20336580 |
| 59 | termination of RNA polymerase III transcription (GO:0006386) | 3.20336580 |
| 60 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.17731611 |
| 61 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.13741306 |
| 62 | GMP metabolic process (GO:0046037) | 3.13448791 |
| 63 | cellular metabolic compound salvage (GO:0043094) | 3.11921084 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.11397527 |
| 65 | establishment of protein localization to mitochondrion (GO:0072655) | 3.10695032 |
| 66 | sulfur amino acid biosynthetic process (GO:0000097) | 3.10427986 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.07701702 |
| 68 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07353756 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.06168027 |
| 70 | protein targeting to mitochondrion (GO:0006626) | 3.05097794 |
| 71 | proline metabolic process (GO:0006560) | 3.03142853 |
| 72 | methionine metabolic process (GO:0006555) | 2.99762574 |
| 73 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.99148366 |
| 74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97391881 |
| 75 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.97355242 |
| 76 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97119313 |
| 77 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.95855914 |
| 78 | histone arginine methylation (GO:0034969) | 2.95841916 |
| 79 | mitochondrion degradation (GO:0000422) | 2.95505343 |
| 80 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.95265969 |
| 81 | de novo posttranslational protein folding (GO:0051084) | 2.92642660 |
| 82 | peptidyl-arginine N-methylation (GO:0035246) | 2.92600712 |
| 83 | peptidyl-arginine methylation (GO:0018216) | 2.92600712 |
| 84 | urate metabolic process (GO:0046415) | 2.92084287 |
| 85 | CTP metabolic process (GO:0046036) | 2.90739536 |
| 86 | CTP biosynthetic process (GO:0006241) | 2.90739536 |
| 87 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.90397278 |
| 88 | sulfur amino acid metabolic process (GO:0000096) | 2.90380574 |
| 89 | regulation of cellular respiration (GO:0043457) | 2.89652531 |
| 90 | rRNA transcription (GO:0009303) | 2.88506839 |
| 91 | L-phenylalanine metabolic process (GO:0006558) | 2.88362705 |
| 92 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.88362705 |
| 93 | N-acetylneuraminate metabolic process (GO:0006054) | 2.87630208 |
| 94 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86795829 |
| 95 | intestinal absorption (GO:0050892) | 2.86659252 |
| 96 | barbed-end actin filament capping (GO:0051016) | 2.84782661 |
| 97 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.82840665 |
| 98 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82469698 |
| 99 | rRNA modification (GO:0000154) | 2.82303012 |
| 100 | heme transport (GO:0015886) | 2.82012407 |
| 101 | positive regulation of mitochondrion organization (GO:0010822) | 2.81555761 |
| 102 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.80419857 |
| 103 | polyamine biosynthetic process (GO:0006596) | 2.80413078 |
| 104 | synaptic vesicle endocytosis (GO:0048488) | 2.79786502 |
| 105 | de novo protein folding (GO:0006458) | 2.78831576 |
| 106 | L-phenylalanine catabolic process (GO:0006559) | 2.78484830 |
| 107 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.78484830 |
| 108 | methionine biosynthetic process (GO:0009086) | 2.78354195 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78329075 |
| 110 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.77058373 |
| 111 | protein localization to mitochondrion (GO:0070585) | 2.76577287 |
| 112 | ubiquinone biosynthetic process (GO:0006744) | 2.75920207 |
| 113 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.75799134 |
| 114 | fructose metabolic process (GO:0006000) | 2.75727228 |
| 115 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.75649318 |
| 116 | positive regulation of pseudopodium assembly (GO:0031274) | 2.75617098 |
| 117 | ribosome biogenesis (GO:0042254) | 2.75291381 |
| 118 | peptidyl-histidine modification (GO:0018202) | 2.75131281 |
| 119 | positive regulation of protein targeting to membrane (GO:0090314) | 2.74316439 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 2.73981486 |
| 121 | L-serine metabolic process (GO:0006563) | 2.72010769 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.71616693 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.71616693 |
| 124 | purine nucleotide salvage (GO:0032261) | 2.70828858 |
| 125 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.70473844 |
| 126 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.69774836 |
| 127 | regulation of mitochondrial translation (GO:0070129) | 2.66955117 |
| 128 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.66087784 |
| 129 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.65503629 |
| 130 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.64944536 |
| 131 | galactose catabolic process (GO:0019388) | 2.64444209 |
| 132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63690404 |
| 133 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62042194 |
| 134 | UTP biosynthetic process (GO:0006228) | 2.61697001 |
| 135 | protein complex biogenesis (GO:0070271) | 2.61291532 |
| 136 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.61102335 |
| 137 | mitochondrial calcium ion transport (GO:0006851) | 2.60870047 |
| 138 | positive regulation of protein sumoylation (GO:0033235) | 2.60825517 |
| 139 | GTP biosynthetic process (GO:0006183) | 2.59790177 |
| 140 | regulation of protein targeting to membrane (GO:0090313) | 2.59537571 |
| 141 | positive regulation of protein depolymerization (GO:1901881) | 2.59166976 |
| 142 | purine nucleobase metabolic process (GO:0006144) | 2.58335247 |
| 143 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.57505625 |
| 144 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.57043831 |
| 145 | nucleoside salvage (GO:0043174) | 2.56155696 |
| 146 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.55983860 |
| 147 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.55983860 |
| 148 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.55422804 |
| 149 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.55297481 |
| 150 | nucleotide-sugar metabolic process (GO:0009225) | 2.55266452 |
| 151 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54877518 |
| 152 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.54733098 |
| 153 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.54723954 |
| 154 | heart contraction (GO:0060047) | 2.52765661 |
| 155 | heart process (GO:0003015) | 2.52765661 |
| 156 | regulation of mitochondrion organization (GO:0010821) | 2.51999203 |
| 157 | regulation of triglyceride catabolic process (GO:0010896) | 2.51681435 |
| 158 | water-soluble vitamin metabolic process (GO:0006767) | 2.51423550 |
| 159 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.51009935 |
| 160 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.50392759 |
| 161 | regulation of cholesterol esterification (GO:0010872) | 2.49215687 |
| 162 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.48763942 |
| 163 | regulation of protein heterodimerization activity (GO:0043497) | 2.47408567 |
| 164 | L-serine transport (GO:0015825) | 2.47253628 |
| 165 | regulation of translation in response to stress (GO:0043555) | 2.46149425 |
| 166 | regulation of pseudopodium assembly (GO:0031272) | 2.46037859 |
| 167 | positive regulation of mitochondrial fission (GO:0090141) | 2.44599066 |
| 168 | alpha-linolenic acid metabolic process (GO:0036109) | 2.44578945 |
| 169 | UV protection (GO:0009650) | 2.44051963 |
| 170 | response to gravity (GO:0009629) | 2.43267191 |
| 171 | folic acid-containing compound metabolic process (GO:0006760) | 2.43139584 |
| 172 | ubiquinone metabolic process (GO:0006743) | 2.43092755 |
| 173 | drug transport (GO:0015893) | 2.42530795 |
| 174 | serine transport (GO:0032329) | 2.42486101 |
| 175 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.41075911 |
| 176 | NADH dehydrogenase complex assembly (GO:0010257) | 2.40128316 |
| 177 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.40128316 |
| 178 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.40128316 |
| 179 | oxidative phosphorylation (GO:0006119) | 2.40044800 |
| 180 | valine metabolic process (GO:0006573) | 2.39927619 |
| 181 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.39091068 |
| 182 | negative regulation of microtubule polymerization (GO:0031115) | 2.38962275 |
| 183 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.38938049 |
| 184 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.38938049 |
| 185 | tRNA modification (GO:0006400) | 2.38649866 |
| 186 | aromatic amino acid family metabolic process (GO:0009072) | 2.38509006 |
| 187 | establishment of viral latency (GO:0019043) | 2.37832620 |
| 188 | high-density lipoprotein particle remodeling (GO:0034375) | 2.34186652 |
| 189 | bile acid and bile salt transport (GO:0015721) | 2.33570636 |
| 190 | mannose metabolic process (GO:0006013) | 2.33235685 |
| 191 | carnitine metabolic process (GO:0009437) | 2.33152954 |
| 192 | negative regulation of ligase activity (GO:0051352) | 2.32388760 |
| 193 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.32388760 |
| 194 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.32368588 |
| 195 | intestinal epithelial cell development (GO:0060576) | 2.29873056 |
| 196 | rRNA methylation (GO:0031167) | 2.29529003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.59003078 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.31841145 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.01793097 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90353690 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79968180 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.71871115 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.64212264 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.63064076 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56752130 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48730154 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.37830573 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.23781008 |
| 13 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20637743 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19343953 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.19335484 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13369850 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11706166 |
| 18 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.07650078 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01041401 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.97871092 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.95934547 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92131743 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85654975 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.83389539 |
| 25 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80303814 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74571038 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.72902284 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.72661653 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70590190 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70122365 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70081745 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69490507 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60526509 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57974131 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56552182 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54453638 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53643097 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52281136 |
| 39 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52042644 |
| 40 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50398967 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47658144 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46556368 |
| 43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44412427 |
| 44 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43978714 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42400745 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42025528 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41917713 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39875967 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39826834 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39414488 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.39040046 |
| 52 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.38455068 |
| 53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38214655 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37220067 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.36825953 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36392819 |
| 57 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35723283 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34465190 |
| 59 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.34283600 |
| 60 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33067797 |
| 61 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32752743 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32403336 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30961192 |
| 64 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.30935939 |
| 65 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.30429628 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29184407 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27773404 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27337321 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26626135 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26365678 |
| 71 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.25761367 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25520217 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.25290930 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25247638 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25097397 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24440715 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24423984 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24093844 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23978800 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23890141 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23435263 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23181607 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23028379 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22687789 |
| 85 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.21190347 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21124482 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21066001 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21060482 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.20476489 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20306840 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17985068 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.17115628 |
| 93 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16661826 |
| 94 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16254115 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15931527 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15883764 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15128133 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15068212 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14814412 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12482679 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11538374 |
| 102 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11106733 |
| 103 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10495946 |
| 104 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09882749 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09773063 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09020569 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08947406 |
| 108 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08658262 |
| 109 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08483723 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08199196 |
| 111 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07551170 |
| 112 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07536704 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06754082 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06430191 |
| 115 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05814317 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05405507 |
| 117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.05191694 |
| 118 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05051144 |
| 119 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05012448 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04986321 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 1.04950202 |
| 122 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04834756 |
| 123 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.04676544 |
| 124 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04624296 |
| 125 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04404659 |
| 126 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04207980 |
| 127 | MAF_26560356_Chip-Seq_TH1_Human | 1.03902024 |
| 128 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02837613 |
| 129 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01909470 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01458990 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01222487 |
| 132 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01054921 |
| 133 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00807545 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99923155 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98332572 |
| 136 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98055205 |
| 137 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97873559 |
| 138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97729533 |
| 139 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97218788 |
| 140 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96958891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 5.43833756 |
| 2 | MP0005360_urolithiasis | 4.45997607 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.33293074 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.76185397 |
| 5 | MP0005365_abnormal_bile_salt | 3.64533805 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.97661217 |
| 7 | MP0001666_abnormal_nutrient_absorption | 2.88969457 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.83781837 |
| 9 | MP0008260_abnormal_autophagy | 2.61753081 |
| 10 | MP0003329_amyloid_beta_deposits | 2.59631351 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56125871 |
| 12 | MP0004270_analgesia | 2.54993646 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.52899254 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.51252538 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.49739759 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.39823691 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.30418836 |
| 18 | MP0003718_maternal_effect | 2.29348728 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.21595658 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 2.19028155 |
| 21 | MP0000751_myopathy | 2.18331547 |
| 22 | MP0005332_abnormal_amino_acid | 2.14647862 |
| 23 | MP0005451_abnormal_body_composition | 2.07312441 |
| 24 | MP0004233_abnormal_muscle_weight | 2.07048943 |
| 25 | MP0001529_abnormal_vocalization | 2.00667805 |
| 26 | MP0002064_seizures | 1.97104245 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.84451938 |
| 28 | MP0000749_muscle_degeneration | 1.81825076 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.80446988 |
| 30 | MP0000609_abnormal_liver_physiology | 1.78384565 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.74209957 |
| 32 | MP0001905_abnormal_dopamine_level | 1.73040548 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.70204062 |
| 34 | MP0005083_abnormal_biliary_tract | 1.69941667 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.68509852 |
| 36 | MP0003866_abnormal_defecation | 1.67724958 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.66653176 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.64896312 |
| 39 | MP0004858_abnormal_nervous_system | 1.62983402 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.62299992 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.60910189 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.60388928 |
| 43 | MP0003878_abnormal_ear_physiology | 1.57162492 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.57162492 |
| 45 | MP0001764_abnormal_homeostasis | 1.56800782 |
| 46 | MP0001756_abnormal_urination | 1.55936337 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.55366347 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.54861224 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.52768555 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.51114445 |
| 51 | MP0009745_abnormal_behavioral_response | 1.48944896 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.47982605 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.46836426 |
| 54 | MP0004147_increased_porphyrin_level | 1.44532324 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.43967697 |
| 56 | MP0002132_abnormal_respiratory_system | 1.43809802 |
| 57 | MP0009046_muscle_twitch | 1.43597342 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.43325373 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.43104934 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.42862890 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.41993223 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.35329737 |
| 63 | MP0004043_abnormal_pH_regulation | 1.33566055 |
| 64 | MP0000490_abnormal_crypts_of | 1.32970720 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.32508145 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.32508145 |
| 67 | MP0000747_muscle_weakness | 1.28169662 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.28142576 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.26122940 |
| 70 | MP0001970_abnormal_pain_threshold | 1.25761020 |
| 71 | MP0005671_abnormal_response_to | 1.25487583 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 1.25052790 |
| 73 | MP0005670_abnormal_white_adipose | 1.24820217 |
| 74 | MP0004947_skin_inflammation | 1.23659875 |
| 75 | MP0005330_cardiomyopathy | 1.23526197 |
| 76 | MP0008874_decreased_physiological_sensi | 1.22059131 |
| 77 | MP0000003_abnormal_adipose_tissue | 1.21791138 |
| 78 | MP0009379_abnormal_foot_pigmentation | 1.21606977 |
| 79 | MP0003634_abnormal_glial_cell | 1.21527955 |
| 80 | MP0003763_abnormal_thymus_physiology | 1.20878274 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.20434539 |
| 82 | MP0001873_stomach_inflammation | 1.18411264 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 1.17767660 |
| 84 | MP0000778_abnormal_nervous_system | 1.16586777 |
| 85 | MP0003724_increased_susceptibility_to | 1.14791584 |
| 86 | MP0010155_abnormal_intestine_physiology | 1.14466571 |
| 87 | MP0008469_abnormal_protein_level | 1.14287809 |
| 88 | MP0003868_abnormal_feces_composition | 1.12399358 |
| 89 | MP0001661_extended_life_span | 1.11308968 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10891159 |
| 91 | MP0002736_abnormal_nociception_after | 1.10258574 |
| 92 | MP0002269_muscular_atrophy | 1.09918133 |
| 93 | MP0008058_abnormal_DNA_repair | 1.09829858 |
| 94 | MP0003436_decreased_susceptibility_to | 1.07617509 |
| 95 | MP0005499_abnormal_olfactory_system | 1.07171118 |
| 96 | MP0005394_taste/olfaction_phenotype | 1.07171118 |
| 97 | MP0002066_abnormal_motor_capabilities/c | 1.07048387 |
| 98 | MP0005501_abnormal_skin_physiology | 1.06843473 |
| 99 | MP0002272_abnormal_nervous_system | 1.06147451 |
| 100 | MP0003186_abnormal_redox_activity | 1.03421710 |
| 101 | MP0005464_abnormal_platelet_physiology | 1.02809522 |
| 102 | MP0000685_abnormal_immune_system | 1.01896836 |
| 103 | MP0008569_lethality_at_weaning | 1.00744967 |
| 104 | MP0002822_catalepsy | 0.99899336 |
| 105 | MP0004957_abnormal_blastocyst_morpholog | 0.99864225 |
| 106 | MP0008932_abnormal_embryonic_tissue | 0.99781870 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.98651635 |
| 108 | MP0000598_abnormal_liver_morphology | 0.98645032 |
| 109 | MP0009053_abnormal_anal_canal | 0.98213074 |
| 110 | MP0003786_premature_aging | 0.97964210 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.97963048 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.97876736 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97232932 |
| 114 | MP0009785_altered_susceptibility_to | 0.95090717 |
| 115 | MP0002796_impaired_skin_barrier | 0.94213921 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.93287104 |
| 117 | MP0003646_muscle_fatigue | 0.93184088 |
| 118 | MP0000049_abnormal_middle_ear | 0.93169529 |
| 119 | MP0002882_abnormal_neuron_morphology | 0.92830099 |
| 120 | MP0000733_abnormal_muscle_development | 0.92397156 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.91930237 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.91678616 |
| 123 | MP0000358_abnormal_cell_content/ | 0.90522030 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.90300056 |
| 125 | MP0005310_abnormal_salivary_gland | 0.90022907 |
| 126 | MP0005025_abnormal_response_to | 0.89720867 |
| 127 | MP0002722_abnormal_immune_system | 0.89647274 |
| 128 | MP0003252_abnormal_bile_duct | 0.89643357 |
| 129 | MP0003879_abnormal_hair_cell | 0.89605776 |
| 130 | MP0002166_altered_tumor_susceptibility | 0.89357104 |
| 131 | MP0004924_abnormal_behavior | 0.89313445 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.89313445 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.87642367 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.87622531 |
| 135 | MP0000681_abnormal_thyroid_gland | 0.86829779 |
| 136 | MP0004742_abnormal_vestibular_system | 0.86490804 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.85575802 |
| 138 | MP0000343_altered_response_to | 0.85347046 |
| 139 | MP0000955_abnormal_spinal_cord | 0.85320802 |
| 140 | MP0002398_abnormal_bone_marrow | 0.84171506 |
| 141 | MP0003123_paternal_imprinting | 0.83634643 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.82845318 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.82330796 |
| 144 | MP0002723_abnormal_immune_serum | 0.81794399 |
| 145 | MP0009764_decreased_sensitivity_to | 0.81280624 |
| 146 | MP0000537_abnormal_urethra_morphology | 0.81227195 |
| 147 | MP0002177_abnormal_outer_ear | 0.81005192 |
| 148 | MP0000604_amyloidosis | 0.80077145 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.79919389 |
| 150 | MP0005084_abnormal_gallbladder_morpholo | 0.79527507 |
| 151 | MP0002106_abnormal_muscle_physiology | 0.79508589 |
| 152 | MP0003941_abnormal_skin_development | 0.78916837 |
| 153 | MP0003195_calcinosis | 0.78415153 |
| 154 | MP0000716_abnormal_immune_system | 0.78323158 |
| 155 | MP0003075_altered_response_to | 0.78092024 |
| 156 | MP0002067_abnormal_sensory_capabilities | 0.78019179 |
| 157 | MP0000538_abnormal_urinary_bladder | 0.77105642 |
| 158 | MP0002429_abnormal_blood_cell | 0.76120131 |
| 159 | MP0001730_embryonic_growth_arrest | 0.76102130 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.75951664 |
| 161 | MP0004510_myositis | 0.74374805 |
| 162 | MP0001727_abnormal_embryo_implantation | 0.73116896 |
| 163 | MP0000013_abnormal_adipose_tissue | 0.72565095 |
| 164 | MP0001346_abnormal_lacrimal_gland | 0.72349465 |
| 165 | MP0005000_abnormal_immune_tolerance | 0.71233420 |
| 166 | MP0001800_abnormal_humoral_immune | 0.71124050 |
| 167 | MP0002078_abnormal_glucose_homeostasis | 0.70339714 |
| 168 | MP0001819_abnormal_immune_cell | 0.70192146 |
| 169 | MP0008438_abnormal_cutaneous_collagen | 0.69813991 |
| 170 | MP0005448_abnormal_energy_balance | 0.69632115 |
| 171 | MP0002152_abnormal_brain_morphology | 0.69484786 |
| 172 | MP0002420_abnormal_adaptive_immunity | 0.69280062 |
| 173 | MP0009765_abnormal_xenobiotic_induced | 0.69141536 |
| 174 | MP0003633_abnormal_nervous_system | 0.67382891 |
| 175 | MP0004087_abnormal_muscle_fiber | 0.66988018 |
| 176 | MP0005075_abnormal_melanosome_morpholog | 0.66827241 |
| 177 | MP0000015_abnormal_ear_pigmentation | 0.66563030 |
| 178 | MP0002249_abnormal_larynx_morphology | 0.65596505 |
| 179 | MP0005266_abnormal_metabolism | 0.64316407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 4.82140922 |
| 2 | Hyperglycinemia (HP:0002154) | 4.79366061 |
| 3 | Gout (HP:0001997) | 4.65853444 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04072976 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 4.04072976 |
| 6 | Ragged-red muscle fibers (HP:0003200) | 3.85573846 |
| 7 | Progressive muscle weakness (HP:0003323) | 3.69976706 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.63256020 |
| 9 | Upper limb amyotrophy (HP:0009129) | 3.60035053 |
| 10 | Distal upper limb amyotrophy (HP:0007149) | 3.60035053 |
| 11 | Hand muscle atrophy (HP:0009130) | 3.53668727 |
| 12 | Increased serum pyruvate (HP:0003542) | 3.52226161 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.48436344 |
| 14 | Pustule (HP:0200039) | 3.36663172 |
| 15 | Myopathic facies (HP:0002058) | 3.28256860 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27680907 |
| 17 | Myokymia (HP:0002411) | 3.22355786 |
| 18 | Retinal dysplasia (HP:0007973) | 3.17935804 |
| 19 | Abnormality of serum amino acid levels (HP:0003112) | 3.17491244 |
| 20 | Entropion (HP:0000621) | 3.17445169 |
| 21 | Insomnia (HP:0100785) | 3.10333323 |
| 22 | Tetraplegia (HP:0002445) | 3.07936422 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 3.06105908 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 3.00658102 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 2.96898202 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.90272434 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86405420 |
| 28 | Difficulty climbing stairs (HP:0003551) | 2.86102593 |
| 29 | Xanthomatosis (HP:0000991) | 2.85348838 |
| 30 | Upper limb muscle weakness (HP:0003484) | 2.81676648 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81440389 |
| 32 | Ankle clonus (HP:0011448) | 2.80960039 |
| 33 | Death in infancy (HP:0001522) | 2.79121620 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.78491147 |
| 35 | Abnormality of alanine metabolism (HP:0010916) | 2.78491147 |
| 36 | Hyperalaninemia (HP:0003348) | 2.78491147 |
| 37 | Hypokinesia (HP:0002375) | 2.76433700 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.70500165 |
| 39 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.67232624 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.67232624 |
| 41 | Hyperacusis (HP:0010780) | 2.64576084 |
| 42 | Cerebral hypomyelination (HP:0006808) | 2.57469399 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.57091500 |
| 44 | Hyperammonemia (HP:0001987) | 2.57060432 |
| 45 | Megaloblastic anemia (HP:0001889) | 2.55747206 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53860125 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 2.53552152 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.51371350 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51371350 |
| 50 | Lethargy (HP:0001254) | 2.45173564 |
| 51 | Cholecystitis (HP:0001082) | 2.43965648 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.43965648 |
| 53 | Irritability (HP:0000737) | 2.42783104 |
| 54 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41419077 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.41208239 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36868170 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.35191530 |
| 58 | Malnutrition (HP:0004395) | 2.34170896 |
| 59 | Impulsivity (HP:0100710) | 2.33548066 |
| 60 | Progressive microcephaly (HP:0000253) | 2.32476806 |
| 61 | CNS demyelination (HP:0007305) | 2.30757600 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 2.30516365 |
| 63 | Acute encephalopathy (HP:0006846) | 2.30486350 |
| 64 | Hepatic necrosis (HP:0002605) | 2.29860768 |
| 65 | Broad distal phalanx of finger (HP:0009836) | 2.28427939 |
| 66 | Visual hallucinations (HP:0002367) | 2.27454872 |
| 67 | Atrioventricular block (HP:0001678) | 2.27269949 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.26579277 |
| 69 | Polycythemia (HP:0001901) | 2.26443105 |
| 70 | Microretrognathia (HP:0000308) | 2.25918543 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.25438909 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.23865759 |
| 73 | Stridor (HP:0010307) | 2.23768882 |
| 74 | Cheilitis (HP:0100825) | 2.23728433 |
| 75 | Ketosis (HP:0001946) | 2.23615724 |
| 76 | Petechiae (HP:0000967) | 2.23335100 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.22271740 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.20707446 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.20160279 |
| 80 | Increased purine levels (HP:0004368) | 2.19979300 |
| 81 | Hyperuricemia (HP:0002149) | 2.19979300 |
| 82 | Bundle branch block (HP:0011710) | 2.19713825 |
| 83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.17796015 |
| 84 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.17796015 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 2.17796015 |
| 86 | Abnormal glycosylation (HP:0012345) | 2.17796015 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.17360049 |
| 88 | Restlessness (HP:0000711) | 2.17211955 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16033199 |
| 90 | Abnormal number of erythroid precursors (HP:0012131) | 2.14109161 |
| 91 | Exercise intolerance (HP:0003546) | 2.13888405 |
| 92 | Athetosis (HP:0002305) | 2.12958537 |
| 93 | Opisthotonus (HP:0002179) | 2.11567650 |
| 94 | Paraparesis (HP:0002385) | 2.10983989 |
| 95 | Ileus (HP:0002595) | 2.10537482 |
| 96 | Amblyopia (HP:0000646) | 2.10381500 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.09418950 |
| 98 | Rough bone trabeculation (HP:0100670) | 2.08842321 |
| 99 | Brushfield spots (HP:0001088) | 2.08616194 |
| 100 | IgM deficiency (HP:0002850) | 2.07614757 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 2.07561136 |
| 102 | Back pain (HP:0003418) | 2.04731476 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.04449171 |
| 104 | Spastic paraparesis (HP:0002313) | 2.02821038 |
| 105 | Truncal ataxia (HP:0002078) | 2.02738543 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.01440584 |
| 107 | Fasciculations (HP:0002380) | 2.01218723 |
| 108 | Increased CSF lactate (HP:0002490) | 2.00935745 |
| 109 | Cholelithiasis (HP:0001081) | 1.99828514 |
| 110 | Vertebral compression fractures (HP:0002953) | 1.99004944 |
| 111 | Premature rupture of membranes (HP:0001788) | 1.98870361 |
| 112 | Type I transferrin isoform profile (HP:0003642) | 1.98122569 |
| 113 | Diminished motivation (HP:0000745) | 1.96947669 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.96213500 |
| 115 | Abnormality of the motor neurons (HP:0002450) | 1.95372732 |
| 116 | Abnormal neuron morphology (HP:0012757) | 1.95372732 |
| 117 | Fat malabsorption (HP:0002630) | 1.94693546 |
| 118 | Global brain atrophy (HP:0002283) | 1.94417070 |
| 119 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.94350575 |
| 120 | Emotional lability (HP:0000712) | 1.92475345 |
| 121 | Akinesia (HP:0002304) | 1.92392581 |
| 122 | Increased serum lactate (HP:0002151) | 1.92372148 |
| 123 | Ureteral duplication (HP:0000073) | 1.91441138 |
| 124 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.90726006 |
| 125 | Trismus (HP:0000211) | 1.90511920 |
| 126 | Pancreatitis (HP:0001733) | 1.90199887 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 1.89947232 |
| 128 | Delusions (HP:0000746) | 1.89472261 |
| 129 | Abnormality of the umbilical cord (HP:0010881) | 1.88424245 |
| 130 | Abnormality of the vocal cords (HP:0008777) | 1.88314282 |
| 131 | Apathy (HP:0000741) | 1.88109554 |
| 132 | Diminished movement (HP:0002374) | 1.87854217 |
| 133 | Growth hormone excess (HP:0000845) | 1.87209663 |
| 134 | Hyperglycemia (HP:0003074) | 1.86209602 |
| 135 | Neonatal onset (HP:0003623) | 1.85694916 |
| 136 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85557607 |
| 137 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85441308 |
| 138 | Polyphagia (HP:0002591) | 1.85255135 |
| 139 | Clonus (HP:0002169) | 1.85246936 |
| 140 | Spinal rigidity (HP:0003306) | 1.85157227 |
| 141 | Thrombocytosis (HP:0001894) | 1.84609399 |
| 142 | Short nail (HP:0001799) | 1.83837460 |
| 143 | Late onset (HP:0003584) | 1.83691477 |
| 144 | Nonimmune hydrops fetalis (HP:0001790) | 1.83511295 |
| 145 | CNS hypomyelination (HP:0003429) | 1.83272509 |
| 146 | Poor suck (HP:0002033) | 1.82989439 |
| 147 | High anterior hairline (HP:0009890) | 1.82365123 |
| 148 | Sparse eyelashes (HP:0000653) | 1.81638351 |
| 149 | Hammertoe (HP:0001765) | 1.81225562 |
| 150 | Progressive macrocephaly (HP:0004481) | 1.80639823 |
| 151 | Depression (HP:0000716) | 1.80324515 |
| 152 | Abnormal platelet function (HP:0011869) | 1.79867142 |
| 153 | Impaired platelet aggregation (HP:0003540) | 1.79867142 |
| 154 | Abnormality of the gallbladder (HP:0005264) | 1.78942372 |
| 155 | Chronic otitis media (HP:0000389) | 1.77929997 |
| 156 | Posterior embryotoxon (HP:0000627) | 1.77855215 |
| 157 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77463947 |
| 158 | Hypoplasia of the brainstem (HP:0002365) | 1.77463947 |
| 159 | Hypercholesterolemia (HP:0003124) | 1.77240598 |
| 160 | Peripheral hypomyelination (HP:0007182) | 1.77147674 |
| 161 | Brittle hair (HP:0002299) | 1.77114575 |
| 162 | Long foot (HP:0001833) | 1.77034644 |
| 163 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76897955 |
| 164 | Breast hypoplasia (HP:0003187) | 1.75852678 |
| 165 | Areflexia of lower limbs (HP:0002522) | 1.75351563 |
| 166 | Neuronal loss in central nervous system (HP:0002529) | 1.74786491 |
| 167 | Delayed CNS myelination (HP:0002188) | 1.74593201 |
| 168 | Testicular atrophy (HP:0000029) | 1.73802528 |
| 169 | Loss of speech (HP:0002371) | 1.73694853 |
| 170 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.73424046 |
| 171 | Nausea (HP:0002018) | 1.73316866 |
| 172 | Metabolic acidosis (HP:0001942) | 1.73167393 |
| 173 | Methylmalonic aciduria (HP:0012120) | 1.72876504 |
| 174 | Abnormal gallbladder morphology (HP:0012437) | 1.72742756 |
| 175 | Foot dorsiflexor weakness (HP:0009027) | 1.72232443 |
| 176 | Lower limb amyotrophy (HP:0007210) | 1.72185442 |
| 177 | Spastic tetraparesis (HP:0001285) | 1.71649214 |
| 178 | Degeneration of anterior horn cells (HP:0002398) | 1.71212782 |
| 179 | Abnormality of the anterior horn cell (HP:0006802) | 1.71212782 |
| 180 | Hypoglycemic coma (HP:0001325) | 1.68847843 |
| 181 | Muscle stiffness (HP:0003552) | 1.67637754 |
| 182 | Lactic acidosis (HP:0003128) | 1.67492092 |
| 183 | Dysautonomia (HP:0002459) | 1.67007550 |
| 184 | Increased connective tissue (HP:0009025) | 1.66375597 |
| 185 | Tongue fasciculations (HP:0001308) | 1.66306224 |
| 186 | Multiple lipomas (HP:0001012) | 1.65858762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.73944765 |
| 2 | ERN1 | 4.22327748 |
| 3 | BCKDK | 4.04964739 |
| 4 | ACVR1B | 3.44258325 |
| 5 | SMG1 | 3.21189552 |
| 6 | VRK2 | 3.20175823 |
| 7 | NME2 | 2.83056809 |
| 8 | STK16 | 2.63658932 |
| 9 | TRIB3 | 2.58800283 |
| 10 | EIF2AK1 | 2.37127277 |
| 11 | AKT3 | 2.36823260 |
| 12 | LIMK1 | 2.31683314 |
| 13 | ARAF | 2.28738347 |
| 14 | PIM2 | 2.23146730 |
| 15 | ZAP70 | 2.17959307 |
| 16 | MAP2K2 | 2.15885673 |
| 17 | MAP2K7 | 2.10866649 |
| 18 | MAP4K1 | 2.10351483 |
| 19 | ICK | 2.09505248 |
| 20 | PINK1 | 2.08141448 |
| 21 | TESK2 | 2.05631880 |
| 22 | WEE1 | 1.97175363 |
| 23 | DAPK1 | 1.96471673 |
| 24 | MARK1 | 1.89195939 |
| 25 | BRAF | 1.83915355 |
| 26 | NEK2 | 1.83740018 |
| 27 | CASK | 1.82257306 |
| 28 | EIF2AK3 | 1.81567568 |
| 29 | FGFR4 | 1.80635439 |
| 30 | CAMKK2 | 1.79272335 |
| 31 | TAF1 | 1.65926117 |
| 32 | PAK6 | 1.64180437 |
| 33 | DYRK3 | 1.62490097 |
| 34 | CSNK1A1L | 1.56622736 |
| 35 | IRAK3 | 1.51318830 |
| 36 | PRKD3 | 1.49387883 |
| 37 | SIK2 | 1.39118584 |
| 38 | CSNK1G2 | 1.36383246 |
| 39 | SIK3 | 1.33958293 |
| 40 | TAOK1 | 1.31808894 |
| 41 | GRK5 | 1.30761343 |
| 42 | NTRK1 | 1.30301605 |
| 43 | PHKG1 | 1.28496376 |
| 44 | PHKG2 | 1.28496376 |
| 45 | TLK1 | 1.28483672 |
| 46 | MAP3K11 | 1.23237971 |
| 47 | TBK1 | 1.21433859 |
| 48 | PDK3 | 1.18209549 |
| 49 | PDK4 | 1.18209549 |
| 50 | DAPK3 | 1.15340105 |
| 51 | TYK2 | 1.14574333 |
| 52 | TAOK2 | 1.14101018 |
| 53 | PRKCI | 1.13348356 |
| 54 | TSSK6 | 1.10075194 |
| 55 | KDR | 1.07380718 |
| 56 | MAPKAPK3 | 1.07304059 |
| 57 | EPHB2 | 1.05222838 |
| 58 | MAP3K9 | 1.02186339 |
| 59 | NLK | 1.01382572 |
| 60 | NME1 | 1.00638853 |
| 61 | TAOK3 | 0.98239090 |
| 62 | BRSK1 | 0.92834827 |
| 63 | LMTK2 | 0.90660270 |
| 64 | CDK4 | 0.88426662 |
| 65 | EPHB1 | 0.86014815 |
| 66 | BRSK2 | 0.85859719 |
| 67 | CDK14 | 0.84181851 |
| 68 | PDK2 | 0.84149138 |
| 69 | GRK6 | 0.82763249 |
| 70 | CDK11A | 0.79854072 |
| 71 | TESK1 | 0.78295474 |
| 72 | CDK15 | 0.77483175 |
| 73 | DYRK2 | 0.76523622 |
| 74 | SYK | 0.76486530 |
| 75 | RAF1 | 0.74689155 |
| 76 | MAPK12 | 0.73912836 |
| 77 | BLK | 0.73554960 |
| 78 | MOS | 0.72837730 |
| 79 | SIK1 | 0.72524923 |
| 80 | PAK4 | 0.72146673 |
| 81 | CDK18 | 0.72076723 |
| 82 | AKT2 | 0.71542478 |
| 83 | CAMK2B | 0.70266213 |
| 84 | MAP3K4 | 0.65400268 |
| 85 | IRAK2 | 0.63843210 |
| 86 | MAP3K3 | 0.63540205 |
| 87 | MARK3 | 0.63429934 |
| 88 | MAPK4 | 0.62452295 |
| 89 | MAP2K4 | 0.61925650 |
| 90 | PDPK1 | 0.61801520 |
| 91 | VRK1 | 0.61567990 |
| 92 | LRRK2 | 0.61523345 |
| 93 | BTK | 0.61436293 |
| 94 | PLK1 | 0.61293805 |
| 95 | ZAK | 0.61284117 |
| 96 | PTK2 | 0.60987303 |
| 97 | PRKD2 | 0.60946071 |
| 98 | CDK19 | 0.60424145 |
| 99 | MARK2 | 0.59393778 |
| 100 | MAP2K6 | 0.57841367 |
| 101 | SRPK1 | 0.57568572 |
| 102 | KSR1 | 0.57430359 |
| 103 | JAK3 | 0.55640591 |
| 104 | STK24 | 0.54231696 |
| 105 | PAK1 | 0.52355088 |
| 106 | PLK4 | 0.51915095 |
| 107 | MAP2K1 | 0.49728062 |
| 108 | AURKA | 0.49705591 |
| 109 | EPHA2 | 0.49231577 |
| 110 | MAP3K12 | 0.49223255 |
| 111 | ILK | 0.49086076 |
| 112 | MAP3K5 | 0.48991807 |
| 113 | IKBKE | 0.48758289 |
| 114 | IRAK4 | 0.48572578 |
| 115 | MAP3K6 | 0.48369404 |
| 116 | DAPK2 | 0.48146042 |
| 117 | TXK | 0.47764343 |
| 118 | PRKAA1 | 0.47666585 |
| 119 | RPS6KA2 | 0.47539723 |
| 120 | PDK1 | 0.46828840 |
| 121 | PIM1 | 0.46005214 |
| 122 | MAPK11 | 0.45744623 |
| 123 | CDC7 | 0.45666736 |
| 124 | CAMKK1 | 0.45349677 |
| 125 | PKN1 | 0.44867968 |
| 126 | KSR2 | 0.44118576 |
| 127 | CDK5 | 0.44051965 |
| 128 | MAPKAPK5 | 0.43651378 |
| 129 | JAK1 | 0.43596909 |
| 130 | RPS6KA4 | 0.43273938 |
| 131 | MAP2K3 | 0.42913017 |
| 132 | MINK1 | 0.41921431 |
| 133 | CAMK2D | 0.41156968 |
| 134 | ABL2 | 0.39917511 |
| 135 | MET | 0.39712200 |
| 136 | TTN | 0.39362383 |
| 137 | MAP3K8 | 0.38561598 |
| 138 | TTK | 0.38046115 |
| 139 | CAMK1D | 0.37737405 |
| 140 | TGFBR1 | 0.36313000 |
| 141 | CSNK1G1 | 0.35834889 |
| 142 | UHMK1 | 0.35604084 |
| 143 | MAP3K10 | 0.35576633 |
| 144 | CHEK2 | 0.34908229 |
| 145 | RIPK1 | 0.34795126 |
| 146 | JAK2 | 0.33233763 |
| 147 | CCNB1 | 0.32523396 |
| 148 | AURKB | 0.31785138 |
| 149 | NEK1 | 0.31537406 |
| 150 | PRPF4B | 0.30651652 |
| 151 | CSNK1G3 | 0.29983668 |
| 152 | CAMK2G | 0.26457446 |
| 153 | PRKG2 | 0.24254881 |
| 154 | CAMK1 | 0.23022238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.99570929 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 4.07165469 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 3.18369557 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.69558537 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.60236409 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.57805427 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.51868139 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.42695674 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37784725 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33648599 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29059045 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18663722 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.16822471 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.14786290 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.13746247 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06896119 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.05936444 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.86108880 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.85336955 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82535193 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.79132625 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.77061743 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76753252 |
| 24 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.75056691 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.73400839 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.67938738 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67092152 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.65318601 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.64814653 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61015506 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58648118 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53785276 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49827112 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49482286 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49249433 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48498631 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48083402 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44727325 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42713090 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39238800 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38015834 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.31990455 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31168782 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27321024 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24348311 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22377380 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19441996 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15257899 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.14086514 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13093732 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.12708011 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12272076 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11778313 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08976199 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08798207 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07173197 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06686818 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05600146 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03665875 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03513038 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 1.00866215 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98625885 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.95481966 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95319621 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94611886 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92410180 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92106583 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89797915 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89595355 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87556090 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.86723771 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85887184 |
| 73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84906702 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81539508 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80990424 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79949230 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79585481 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78252628 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76826439 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76383047 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.74870942 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.73162463 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72769842 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72748101 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71576940 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69658128 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68904968 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.68791703 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.66514174 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.66289972 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65860016 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65681653 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63431227 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.63024618 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62864857 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.62547052 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61811724 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60488087 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58587072 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58438443 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.57525256 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57390010 |
| 103 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56800899 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55786046 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55640410 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55530787 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.54272824 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.53613726 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52322801 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51255213 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50867122 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.50246337 |
| 113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48028656 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46281811 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45876329 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45753967 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45440794 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44562073 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.44325682 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43503045 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43447034 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.42267173 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41251944 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40444621 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40106464 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39216861 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.37357978 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37006592 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36331033 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36201764 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | 0.36161598 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35973309 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35749972 |
| 134 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35014965 |
| 135 | DNA replication_Homo sapiens_hsa03030 | 0.33869079 |
| 136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33670869 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33309469 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32977078 |
| 139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32852444 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32756662 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32691875 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.32653160 |
| 143 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31838252 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31687165 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31686848 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.30051911 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29356306 |
| 148 | Spliceosome_Homo sapiens_hsa03040 | 0.28166823 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27404809 |
| 150 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.27055629 |
| 151 | Legionellosis_Homo sapiens_hsa05134 | 0.26904907 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24791818 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22898834 |
| 154 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21920913 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20334221 |
| 156 | Cell cycle_Homo sapiens_hsa04110 | 0.18156778 |

